Editorial: The development of lethal prostate cancer

Baotong Zhang; Sifeng Qu; Xin Li; Xinpei Ci; Jiang Chang

doi:10.3389/fcell.2023.1156392

Editorial: The development of lethal prostate cancer

Front Cell Dev Biol. 2023 Feb 21:11:1156392. doi: 10.3389/fcell.2023.1156392. eCollection 2023.

Authors

Baotong Zhang¹, Sifeng Qu^{2

3}, Xin Li⁴, Xinpei Ci⁵, Jiang Chang⁶

Affiliations

¹ Department of Human Cell Biology and Genetics, School of Medicine, Southern University of Science and Technology, Shenzhen, China.
² Medical Integration and Practice Center, Cheeloo College of Medicine, Shandong University, Jinan, Shandong, China.
³ Department of Urology, Qilu Hospital, Cheeloo College of Medicine, Shandong University, Jinan, Shandong, China.
⁴ Center for Cancer Research and Therapeutic Development and Department of Biological Sciences, Clark Atlanta University, Atlanta, GA, United States.
⁵ Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada.
⁶ Key Laboratory for Environment and Health, Department of Health Toxicology, School of Public Health, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.

No abstract available

Keywords: NEPC; PSMA-based PET imaging; biopsy; natural product; phenotypic plasticity; prostate cancer; therapeutic resistance; tumor microenvironment (TME).

Publication types

Editorial

Grants and funding

This work was supported by the grant 82273079 from the National Natural Science Foundation of China, the grant JCYJ20220530113609020 from Science, Technology and Innovation Commission of Shenzhen Municipality, the grant 2021QN02Y875 from Department of Science and Technology of Guangdong Province, the grants 2021A1515110051 and 2021A1515220181 from GuangDong Basic and Applied Basic Research Foundation, the grant ZR2020MH264 from Shandong Provincial Natural Science Foundation.